COAG (Hemab Therapeutics Holdings, Inc. Common Stock) Stock Analysis - SEC Filings
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is a publicly traded the market company. As of May 21, 2026, COAG trades at $26.47 with a market cap of $1.27B and a P/E ratio of 0.00. COAG moved +2.40% today. Year to date, COAG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $23.00 to $36.61. Rallies surfaces COAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Where can I find COAG SEC filings?
Rallies organizes COAG SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.